News

Syndax Pharmaceuticals Gears Up for September Investor Events

Syndax Pharmaceuticals Gears Up for September Investor Events

Syndax Pharmaceuticals Gears Up for September Investor Events

NEW YORK — Syndax Pharmaceuticals (Nasdaq: SNDX), a biopharmaceutical company dedicated to developing innovative cancer therapies, is excited to announce that Michael A. Metzger, the Chief Executive Officer, along with key members of the management team, will be attending several important investor conferences this September.

Upcoming Conferences and Presentations

The first conference on the agenda is the Citi’s 2025 BioPharma Back to School Conference, where Syndax will participate in a fireside chat scheduled for September 2 at 4:45 p.m. ET. This engaging session will provide insights into the company's strategic initiatives and future directions.

H.C. Wainwright Global Investment Conference

Following that, Syndax will be featured in the H.C. Wainwright 27th Annual Global Investment Conference on September 8 at 9:00 a.m. ET. This platform will not only highlight Syndax's innovative cancer therapies but also showcase the company's achievements and ongoing research efforts to a diverse investor audience.

Webcasts for Broader Engagement

For those unable to attend in person, a live webcast of both conference sessions will be available through the Investor section of the Syndax website. There will also be a replay accessible for a limited time, allowing investors and interested parties to catch up on the discussions and presentations.

About Syndax Pharmaceuticals

Syndax Pharmaceuticals stands at the forefront of innovation within the biopharmaceutical industry, particularly in the realm of cancer treatment. The company is renowned for its advancements, notably the FDA-approved menin inhibitor, Revuforj (revumenib), and the monoclonal antibody Niktimvo™ (axatilimab-csfr), which targets the CSF-1 receptor. These groundbreaking treatments are part of Syndax's larger commitment to reimagine cancer care.

Commitment to Clinical Trials

With a focus on maximizing the potential of its diverse pipeline, Syndax is actively engaged in several clinical trials across a broad spectrum of cancer therapies. This robust pipeline is a testament to Syndax's dedication to improving patient outcomes and advancing the standard of care in oncology.

Stay Informed and Connected

For further details about Syndax Pharmaceuticals, including their comprehensive portfolio of treatments and ongoing clinical trials, visit their website. Additionally, you can follow the latest company updates and insights on professional platforms to stay informed about their continuing journey in cancer therapeutics.

Syndax Contacts

For more inquiries, please reach out to Sharon Klahre at Syndax Pharmaceuticals, Inc. via email: sklahre@syndax.com or call at 781.684.9827.

Frequently Asked Questions

What is Syndax Pharmaceuticals known for?

Syndax Pharmaceuticals is recognized for its innovative cancer therapies, particularly its pipeline including Revuforj and Niktimvo.

When are the conferences taking place?

The conferences are scheduled for September 2 and September 8.

How can I access the conference presentations?

A live webcast will be available on the Syndax website, including replays for later viewing.

Who will be presenting for Syndax at the conferences?

Michael A. Metzger, the CEO of Syndax, along with the management team, will be presenting at the investor conferences.

What is Syndax's commitment to cancer treatment?

Syndax is committed to advancing innovative therapies and conducting multiple clinical trials to enhance cancer care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 3

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
Hainan Airlines' Dedication Keeps It atop Skytrax

Updated Category News Views 5

Fifteen years of soaring high: now that's something worth taking to the bank—or the air. Hainan Airlines has just bagged the SKYTRAX Five-Star Airline rating once again, handed out at this year's World Airline Awards ceremony. When it comes to delivering quality, they're flying high on the charts, landing among the World's Best Airlines Top 10. And in the wild world of...

Continue Reading
PayPal Under Investigation: Legal Battles Intensify

Updated Category News Views 3

A Bumpy Ride for PayPal's Investors Back in 2025, PayPal was beaming about new growth strategies, filling the air with grandiose promises. Fast forward to February 2026, and the script had flipped entirely. Earnings came in nasty and disappointing, particularly in the Branded Checkout front. Adding to the chaos was their CEO unceremoniously taking the high road out the...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 3

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
Shanghai's Arts Carnival Fuses Tech and Culture

Updated Category News Views 2

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Continue Reading
Quay Dominates 2026 Sunglasses Review for Variety

Updated Category News Views 4

Sunglasses Designed for Every Face Type When it comes to picking the right pair of shades, face shape is only part of the equation. Expert Consumers just dropped their 2026 verdict, spotlighting Quay as the go-to brand for those wider faces, tricky nose bridges, and the noggins that run a tad larger than average. Forget what you heard about one-size-fits-all. This...

Continue Reading
Beta Bionics Lawsuit Deadline: Investors Face November 3 Cut-off

Updated Category News Views 4

Looming Deadline for Beta Bionics Investors Time's ticking fast for those holding onto Beta Bionics (BBNX) stock who might've been caught in a web of undisclosed risks and regulatory misses. Investors feeling the pinch from this fiasco have till November 3, 2026, to throw their hat in the ring as lead plaintiffs in the class action lawsuit out of California. The...

Continue Reading
BarrelPick.com Launches for Bourbon Aficionados

Updated Category News Views 3

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Continue Reading
GAC's Cambodia Plant: A Strategic Manufacturing Shift

Updated Category News Views 3

Setting the Stage for New Industrial Growth On September 17, a milestone was etched in the sands of Cambodia when the GAC Cambodia KD Plant officially flipped the switch. This ain't just another factory throwing doors open; it's a fresh chapter in regional manufacturing power plays. We had some big hitters in attendance, like Cambodian Prime Minister Hun Manet, showing...

Continue Reading
USPS Rolls Out Christmas Cookie Stamps Nationwide

Updated Category News Views 2

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Growth in the Perimeter Intruder Detection Sector

Updated Category News Views 116

Perimeter Intruder Detection System Market Size & Growth Insights The global market for Perimeter Intruder Detection Systems (PIDS) is witnessing a remarkable surge. In recent estimates, the market size was assessed at approximately USD 20.05 billion, with projections indicating it could rise to an impressive USD 60.39 billion by 2032. This translates to a compound annual...

Continue Reading
Analyzing Kinsale Capital Group's Surge in Short Interest

Updated Category News Views 116

Understanding Short Interest for Kinsale Capital Group Kinsale Capital Group Inc (KNSL) has recently witnessed a noteworthy rise in its short percent of float, which now stands at 12.22%. This figure indicates that approximately 1.54 million shares are currently sold short, accounting for 6.98% of the total shares available for trading. Based on current trading volumes,...

Continue Reading
Broadpin Celebrates Achievement with Prestigious Oracle Award

Updated Category News Views 148

Broadpin's Prestigious Award Recognition Award celebrates consulting firm's excellence in delivering transformative Oracle solutions for global enterprises. Broadpin, a global Oracle consulting leader formed from the unification of Project Partners, PROMATIS, Quistor, and PITSS, has been named the Winner of the 2025 Oracle Global Service Partner Tech/Cloud Customer...

Continue Reading
Bitwise Asset Management Transitions ETFs With Innovative Strategies

Updated Category News Views 83

Bitwise Asset Management Innovates with Trendwise Strategies Crypto specialist Bitwise Asset Management has announced an exciting transition for its three crypto futures exchange-traded funds (ETFs). These changes mark a significant step forward as the company shifts from traditional long-only strategies to unique Trendwise strategies. This new approach revolves around...

Continue Reading
Emergent BioSolutions Takes Important Steps Against Opioid Crisis

Updated Category News Views 146

Emergent BioSolutions Takes Critical Steps Against Opioid Crisis In an effort to combat the escalating opioid poisoning epidemic, Emergent BioSolutions Inc. (NYSE: EBS) has renewed its commitment to fighting this public health crisis through a multi-faceted approach. This includes promoting awareness, education, and ensuring wide access to life-saving naloxone treatments,...

Continue Reading